ImmuCell buys rights to calf medication gel syringe
Photo Credit / ImmuCell Stock Photo
ImmuCell has bought the rights to a plastic syringe to insert a gel version of its anti-diarrhea medicine into newborn calves.
Biotech company ImmuCell Corp. (NasdaqCM: ICCC) of Portland will pay $350,000 to $550,000 over the next three years to a Minnesota company for the rights to an alternative medicine delivery method for its diarrhea medicine to newborn calves.
Its First Defense medicine has been given to the animals orally in pills administered by a balling gun that was stuck down a calf’s throat, but the new method will use a large but shorter plastic syringe to insert a gel-like paste version of the medication, which is preferable to both farmers and mother cows, according to the Portland Press Herald.
The medicine helps prevent scours, which causes diarrhea and dehydration in the newborns. It is a product made from cow’s milk and is approved for organic farming, the newspaper said.
ImmuCell bought the device from DAY 1, a Minnesota-based veterinary consulting company that it had initially hired to develop and manufacture the gel version in 2012, according to the Press Herald. The paper said ImmuCell initially thought the gel would be a niche product, but after the gel became popular it wanted more control over its own ability to make and sell the gel going forward.
Read more
Most Recent
Most Recent
Comments